Selected Publications
- A Randomized Phase II Study of Efmarodocokin Alfa, an interleukin-22 Agonist, Versus Vedolizumab in Patients With Ulcerative Colitis. Silvio Danese, Michael E. Rothenberg, Jeremy J. Lim, Han Ting Ding, Jacqueline M. McBride, Yiling Chen, Ajit Dash, Jordan S. Mar, Mary Keir, Laurent Peyrin-Biroulet, Julian Panes, Jean Frederic Colombel, Brian Feagan, John F. Valentine, Stefan Schreiber. Clinical Gastroenterology and Hepatology
- Epstein-Barr Virus Exposure Precedes Crohn's Disease Development. Anubhab Nandy, Francesca Petralia, Chad K. Porter, Stephen Elledge, Rajsavi Anand, Kenneth Croitoru, Gus Dunn, Evida Dennis-Heyward, Ally Eran, Michael Field, Katherine Freer, Benjamin E. Gewurz, Abigail Glick, Bruce Horwitz, Tomasz Kula, Ryan Kelly, Sun ho Lee, Renee M. Laird, Natalie Pica, Tamar Parmet, Mark Riddle, Joana Torres, Williams Turpin, Pei Wang, Sydney Whitcomb, Jean Frederic Colombel, Scott B. Snapper. Gastroenterology
- Distinct perturbances in metabolic pathways associate with disease progression in inflammatory bowel disease. Arno R. Bourgonje, Susanne Ibing, Alexandra E. Livanos, Danielle Y. Ganjian, Carmen Argmann, Bruce E. Sands, Marla C. Dubinsky, Drew S. Helmus, Henrik A. Jacobsen, Lone Larsen, Tine Jess, Mayte Suarez-Fariñas, Bernhard Y. Renard, Jean Frédéric Colombel, Ryan C. Ungaro. Journal of Crohn's and Colitis